YaoGeJu

Company directoryChina company filings

Zhejiang Zhebei Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Zhejiang Zhebei Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 7 active records with this name as holder; 7 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

17 acceptance records as first applicant, grouped into 14 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2026/08/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601871Generic2026/08/03Zhejiang Zhebei Pharmaceutical Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanizedCDE ↗
Ethyl Iosapentate Capsules 1 records · Latest accepted 2026/07/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601563Generic2026/07/02Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Eldecalcitol Soft Capsules 2 records · Latest accepted 2025/12/05

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504191Generic2025/12/05Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
CYHS2504190Generic2025/12/05Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Valacyclovir Hydrochloride Tablets 1 records · Latest accepted 2025/08/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502932Generic2025/08/12Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
瑞巴派特片 · No verified English name 1 records · Latest accepted 2025/05/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501934Generic2025/05/30Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Colchicine Tablets 1 records · Latest accepted 2025/01/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500508Generic2025/01/27Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Amisulpride Oral Solution 1 records · Latest accepted 2024/12/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404541Generic2024/12/26Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Aripiprazole Oral Solution 1 records · Latest accepted 2024/12/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404139Generic2024/12/03Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Betamethasone Sodium Phosphate Injection 2 records · Latest accepted 2024/07/30

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401135Supplement2024/07/30Zhejiang Zhebei Pharmaceutical Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2400710Generic2024/02/28Zhejiang Zhebei Pharmaceutical Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD.CDE ↗
骨化三醇胶丸 · No verified English name 1 records · Latest accepted 2024/05/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401354Generic2024/05/08Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Minoxidil Liniment 2 records · Latest accepted 2024/04/24

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401225Generic2024/04/24Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
CYHS2401224Generic2024/04/24Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
青霉素皮试剂 · No verified English name 1 records · Latest accepted 2024/02/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400237Supplement2024/02/08Zhejiang Zhebei Pharmaceutical Co., Ltd.; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.CDE ↗
Pregabalin Oral Solution 1 records · Latest accepted 2023/10/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302826Generic2023/10/21Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Mercaptopurine Tablets 1 records · Latest accepted 2021/04/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150547Supplement2021/04/23Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Rosuvastatin Calcium and Ezetimibe Tablets (I) CYHS2601871Generic2026/08/03Zhejiang Zhebei Pharmaceutical Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanizedCDE ↗
Ethyl Iosapentate Capsules CYHS2601563Generic2026/07/02Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Eldecalcitol Soft Capsules CYHS2504191Generic2025/12/05Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Eldecalcitol Soft Capsules CYHS2504190Generic2025/12/05Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Valacyclovir Hydrochloride Tablets CYHS2502932Generic2025/08/12Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
瑞巴派特片 · No verified English name CYHS2501934Generic2025/05/30Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Colchicine Tablets CYHS2500508Generic2025/01/27Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

7 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Betamethasone Sodium Phosphate InjectionZhejiang Zhebei Pharmaceutical Co., Ltd.ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD.国药准字H202631582026/01/20Generic approved under the new chemical-drug registration classificationCDE ↗
Calcitriol Soft CapsulesZhejiang Zhebei Pharmaceutical Co., Ltd.Zhejiang Zhebei Pharmaceutical Co., Ltd.国药准字H202551302025/08/19Generic approved under the new chemical-drug registration classificationCDE ↗
Mercaptopurine TabletsZhejiang Zhebei Pharmaceutical Co., Ltd.Zhejiang Zhebei Pharmaceutical Co., Ltd.国药准字H330200012021/12/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ribavirin TabletsZhejiang Zhebei Pharmaceutical Co., Ltd.Zhejiang Zhebei Pharmaceutical Co., Ltd.国药准字H109401092021/05/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ribavirin TabletsZhejiang Zhebei Pharmaceutical Co., Ltd.Zhejiang Zhebei Pharmaceutical Co., Ltd.国药准字H109400142021/05/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Acyclovir TabletsZhejiang Zhebei Pharmaceutical Co., Ltd.Zhejiang Zhebei Pharmaceutical Co., Ltd.国药准字H330200052020/11/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Acyclovir TabletsZhejiang Zhebei Pharmaceutical Co., Ltd.Zhejiang Zhebei Pharmaceutical Co., Ltd.国药准字H330200042020/11/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

7 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
巯嘌呤 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20250001464I2026/01/05CDE ↗
甲氨蝶呤 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20240000793A2026/04/29CDE ↗
阿昔洛韦 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20190008308A2023/12/02CDE ↗
利巴韦林 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20190007498A2024/02/05CDE ↗
氨酪酸 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20190007495A2024/02/05CDE ↗
盐酸西替利嗪 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20190007487A2024/02/05CDE ↗
甲磺酸左氧氟沙星 · No verified English nameZhejiang Zhebei Pharmaceutical Co., Ltd.Y20190004320A2024/12/11CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

18 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Fosfomycin Sodium For Injection CYHS2602780Generic2026/11/11Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Fosfomycin Sodium For Injection CYHS2602779Generic2026/11/11Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Fosfomycin Sodium For Injection CYHS2602778Generic2026/11/11Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Minoxidil Liniment CYHB2601726Supplement2026/09/11Hunan Kerey Pharmaceutical Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Minoxidil Liniment CYHB2601725Supplement2026/09/11Hunan Kerey Pharmaceutical Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
双氯芬酸钠搽剂 · No verified English name CYHS2600704Generic2026/03/24Jing Shi (Hangzhou) Pharma Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Colchicine Tablets CYHS2600303Generic2026/01/29Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Bifonazole Solution CYHS2502740Generic2025/07/30Anhui Tai Du Biopharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Pregabalin Oral Solution CYHS2502452Generic2025/07/09Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets CYHB2501180Supplement2025/06/12Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Bifonazole Solution CYHS2501987Generic2025/06/05Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Colchicine Tablets CYHS2501148Generic2025/03/22Yi Jia Pharma (Hubei) Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
硫唑嘌呤片 · No verified English name CYHB2402069Supplement2024/12/06Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
磷酸腺嘌呤片 · No verified English name CYHB2301702Supplement2023/07/29Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Methotrexate Tablets CYHS2300574Generic2023/02/18Jiangsu Bai Ao Xin Kang Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Tadalafil Tablets CYHS2201734Generic2022/10/14Hangzhou Shang He Health Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Ribavirin Tablets CYHB2201155Supplement2022/07/14Bai Shan Technology (Hu Zhou) Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗
Acyclovir Tablets CYHB2200783Supplement2022/05/12Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.